Do you want to read an article? Please log in or register.
Delphi Panel on Neuromodulation as a Treatment Strategy for Dry Eye Disease: Unlocking the Potential of Natural Tear Production
Dry Eye Disease
Related content
Dry Eye Disease
Topical Pharmacologic Treatments for Dry Eye Disease: A Systematic Review
Ocul Surf
Tong L, Liu Z, Şahin A, Gümüş K, Messmer EM, Benítez-Del-Castillo JM, Labetoulle M, Chan CC, Periman LM
doi: 10.1016/j.jtos.2025.07.010
RECOMMENDED
Dry Eye Disease
The impact of dry eye disease on patient-reported quality of life: a Save Sight Dry Eye Registry study
★ 3
Recommended by
Prof. emer. Dr Josef Flammer, Faculty Member
Ocul Surf
Kandel H, Stapleton Ao F, Downie LE, Chidi-Egboka N, Botin DM, Arnalich-Montiel F, Rauz S, Recchioni A, Sitaula S, Markoulli M, Daien V, Babeau F, Geerling G, Craig JP, Watson Oam SL
doi: 10.1016/j.jtos.2025.02.005
Dry Eye Disease
Investigating the Relative Importance of Tear Homeostatic Signs for the Diagnosis of Dry Eye Disease
Ocul Surf
Wolffsohn JS, Travé-Huarte S, Stapleton F, Downie LE, Schulze MM, Guthrie S, Stahl U, Wang MTM, Craig JP
doi: 10.1016/j.jtos.2025.01.010
Further Publications
Identification of tear lipid biomarkers in women with dry eye disease and the impact of intense pulsed light therapy: a case-control study
BMC Ophthalmol
Acera A, Ibarrondo O, Mateo-Orobia AJ, Pereiro X, Abad-García B, López-Plandolit S, Ruzafa N, Romero M, Blasco-Martínez A, Rodríguez FD, Duran JA, Vecino E
doi: 10.1186/s12886-025-04315-1
Dry Eye Disease
Clinical practice patterns in the management of dry eye disease: A TFOS international survey 2023-4
Ocul Surf
Wolffsohn JS, Semp DA, Dutta D, Jones L, Craig JP, TFOS ambassadors
doi: 10.1016/j.jtos.2024.12.008
Dry Eye Disease
A large hypothesis-free proteomics study investigating serum inflammatory markers as biomarkers of dry eye disease
Ocul Surf
Vehof J, Rhee A, Rossi N, Falchi M, Hammond CJ, Williams FMK
doi: 10.1016/j.jtos.2025.01.011
Dry Eye Disease
Diagnostic Cut-Off Values Based on Lipid Layer Pattern for Dry Eye Disease Subtypes Assessment
J Clin Med
Sabucedo-Villamarin B, Garcia-Queiruga J, Pena-Verdeal H, Garcia-Resua C, Yebra-Pimentel E, Giraldez MJ
doi: 10.3390/jcm14020623
Dry Eye Disease
Acoltremon Ophthalmic Solution 0.003% for Signs and Symptoms of Dry Eye Disease: Results of Phase 3 Pivotal Studies COMET-2 and COMET-3
Ophthalmology
Pattar GR, Wirta D, Jerkins G, Paauw J, McLaurin EB, Liu A, Evans DG, Kenyon K, Cline N, Gupta PK, Meng I, Senchyna M, COMET-2 and COMET-3 study groups
doi: 10.1016/j.ophtha.2025.09.018
Further Publications
Exploring tear fluid biomarkers and the ocular surface in thyroid eye disease
Acta Ophthalmol
Neset MT, Nilsen RM, Løvås K, Halsøy K, Reikvam H, Stokland AM, Ueland GÅ, Wolff ASB, Aass HCD, Reppe S, Husebye ES, Rødahl E, Utheim TP, Ueland HO
doi: 10.1111/aos.17556